CVS HEALTH CORPORATION $1,000,000,000 2.125% Senior Notes due 2031 Underwriting AgreementUnderwriting Agreement • August 11th, 2021 • CVS HEALTH Corp • Retail-drug stores and proprietary stores • New York
CVS Health Corporation, a Delaware corporation (the “Company”), proposes to issue and sell $1,000,000,000 aggregate principal amount of its 2.125% Senior Notes due 2031 (the “Notes”) to the several underwriters named on Schedule I hereto (the “Underwriters”), for which Barclays Capital Inc., BofA Securities, Inc. and J.P. Morgan Securities LLC are acting as representatives (the “Representatives”). The Notes will (a) have terms and provisions which are summarized in the Disclosure Package as of the Applicable Time and the Prospectus dated as of the date hereof (each as defined in Section 1(a) hereof) and (b) be issued pursuant to an Indenture dated as of August 15, 2006 (the “Indenture”) between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee (the “Trustee”). This agreement (this “Agreement”) is to confirm the agreement concerning the purchase of the Notes from the Company by the Underwriters.
